Phase II Study of an Association of L-Asparaginase-Methotrexate-Dexamethasone for Relapsing and/or Refractory Nasal and Nasal-Type NK [natural killer]-T-Cell Lymphoma.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 17 Sep 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Asparaginase (Primary) ; Crisantaspase (Primary) ; Dexamethasone; Methotrexate
Indications Non-Hodgkin's lymphoma
Focus Therapeutic Use

13 Jan 2012 Planned end date changed from 1 Jun 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
03 Sep 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
06 Oct 2009 Planned number of patients changed from 30 to 40 as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com